Andy White

Background

About Andy White

Transitioning from laboratory innovation to commercial-scale production presents numerous hurdles. We provide comprehensive solutions to address these critical challenges: • Facility Limitations: Access our state-of-the-art, open-access facilities, equipped with world-class instrumentation and expert personnel. Engage our services on a project-specific basis, eliminating the need for substantial upfront capital investment. • Process & Analytical Discrepancies: Encountering unexpected molecule behavior or analytical results during scale-up? Our experienced team, leveraging advanced analytical equipment and MSAT (Manufacturing Science and Technology) expertise, will identify root causes and implement effective solutions. • Financial & Investment Concerns: Mitigate financial risk by validating your molecule at scale within our facilities, generating robust data packages to meet investment milestones. We accelerate your time-to-market, ensuring optimal valuation and maximizing return on investment. • Data Integrity & Valuation: Address data inconsistencies and ensure reliable results with our rigorous analytical methods. We provide the evidence necessary to confidently secure investment and achieve the desired valuation for your company or molecule. We provide support with: • Internal funding lack for drug development. CDMOs impose IP restrictions, limiting flexibility and profit. Open-access facilities offer expert teams, equipment, and flexible project terms. No IP lock-in; tech transfer to your chosen manufacturer. • Implementing autonomous manufacturing is complex, data integration is difficult, and ROI is uncertain: a) Collaborative space for problem-solving with peers, sharing costs and outcomes. b) Modular digital architecture roadmap, enabling phased implementation and demonstrable ROI. • Dispersed capabilities across locations create logistical hurdles: Integrated scale-up, tech-transfer, and GMP manufacturing in a single location with a unified team. • Certain innovation challenges exceed individual company resources: Collaborative environment for cost-sharing on large-scale manufacturing innovation, with shared access to results. Please connect with or email me. There is no cost to exploring your options. andrew.white@uk-cpi.com